Antibodies specific to phosphorylated peptides are readily generated through structure-based engineering and in vitro selection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Koerber, J.T., Thomsen, N.D., Hannigan B.T., Degrado, W.F. & Wells J.A., Nat. Biotechnol. 31, 916–921 (2013).
Hunter, T. Curr. Opin. Cell Biol. 21, 140–146 (2009).
Olsen, J.V. et al. Cell 127, 635–648 (2006).
Brumbaugh, K. et al. Methods Mol. Biol. 717, 3–43 (2011).
Shih, H. et al. J. Biol. Chem. 287, 44425–44434 (2012).
Bradbury, A.R., Sidhu, S., Dübel, S. & McCafferty, J. Nat. Biotechnol. 29, 245–254 (2011).
Marx, V. Nat. Methods 10, 829–833 (2013).
Stoevesandt, O. & Taussig, M.J. New Biotechnol. 29, 511–514 (2012).
Uhlén, M. et al. Nat. Biotechnol. 28, 1248–1250 (2010).
Hornbeck, P.V. et al. Nucleic Acids Res. 40 Database issue, D261–D270 (2012).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Stoevesandt, O., Taussig, M. Phospho-specific antibodies by design. Nat Biotechnol 31, 889–891 (2013). https://doi.org/10.1038/nbt.2712
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2712
This article is cited by
-
Tools, tactics and objectives to interrogate cellular roles of O-GlcNAc in disease
Nature Chemical Biology (2022)